Optimal frequency of patient monitoring and intensity of oral anticoagulation therapy in valvular heart disease

Journal of Thrombosis and Thrombolysis

Volumn 5, Issue SUPPL. 1, 1998, Pages

  Horstkotte, Dieter ^a   Piper, Cornelia ^a   Wiemer, Marcus ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Heart valve disease; Heart valve prostheses; Oral anticoagulation; Point of care testing; Prothrombin time

Indexed keywords

ANTICOAGULANT AGENT; PHENPROCOUMON;

ANTICOAGULANT THERAPY; BLEEDING; CONFERENCE PAPER; HEART ATRIUM CONTRACTION; HEART ATRIUM FIBRILLATION; HEART LEFT ATRIUM; HEART LEFT VENTRICLE FUNCTION; HEART VALVE PROSTHESIS; HUMAN; ORAL DRUG ADMINISTRATION; PATHOPHYSIOLOGY; PATIENT MONITORING; PRIORITY JOURNAL; PROGNOSIS; THROMBOEMBOLISM; THROMBOGENESIS; VALVULAR HEART DISEASE;

EID: 0031937723     PISSN: 09295305     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Horstkotte D. Abnormal cardiac anatomy and physiology. In: Butchart EG, Bodnar E, ed. Thrombosis, Embolism and Bleeding. London: ICR Publishers, 1992:31-69.
2. Horstkotte D, Scharf RE, Schultheiß HP. Intracardiac thrombosis: Patient-related and device- related factors. J Heart Valve Dis 1995;4:114-120.
3. Levine M, Roskob GE, Landefeld CS, Hirsh J. Hemorrhagic complications of anticoagulant treatment. Chest 1995;108:S276-S290.
4. Cook DJ, Guyatt GH, Laupacis H, Sackett DL, Goldberg RJ. Clinical recommendations using level of evidence for antithrombotic agents. Chest 1995;108:S227-S230.
5. Evidence-Based Medicine Working Group. Evidence-based medicine: A new approach to teaching the practice of medicine. JAMA 1992;268:2420-2425.
6. Bodnar E, Horstkotte D. Potential flaws in the assessment of minor cerebrovascular events after heart valve replacement. J Heart Valve Dis 1993;2:287-290.
7. Edmunds LH, Clark RE, Cohn LH, Miller DC, Weisler RD. Guidelines for reporting morbidity and mortality after cardiac valvular operations. Ann Thorac Surg 1988;46:257-259.
8. Horstkotte D, Schulte HD, Bircks W, Strauer BE. Unexpected findings concerning thromboembolic complications and anticoagulation after complete 10 year follow-up of patients with St. Jude Medical prostheses. J Heart Valve Dis 1993;2:291-301.
9. Horstkotte D, Niehues R, Strauer BE. Pathomorphological aspects, aetiology and natural history of aquired mitral valve stenosis. Eur Heart J 1991;12(Suppl. B):55-60.
10. Levine HJ, Pauker StG, Eckman MH. Antithrombotic therapy in valvular heart disease. Chest 1995;108:360S-370S.
11. Gohlke-Bärwolf C, Acar J, Oakley C, et al. Guidelines for prevention of thromboembolic events in valvular heart disease. Eur Heart J 1995;16:1320-1330.
12. Piper C, Schulte HD, Horstkotte D. Optimization of oral anticoagulation of patients with mechanical heart valve prostheses. J Heart Valve Dis 1995;4:127-137.
13. Karnofsky D, Burchenai AJH. The clinical evaluation of chemotherapeutic agents in cancer. In: MacLeod CM, ed. Symposium held at New York Academy of Medicine. Columbia University Press, 1949;191-205.
14. Horstkotte D, Burckhardt, D. Prosthetic valve thrombosis. J Heart Valve Dis 1995;4:141-153.
15. Stein PJ, Alpert JS, Copeland J, Dalen E, Goldman ST, Turpie AGG. Antithrombotic therapy in patients with mechanical and biological prosthetic heart valves. Chest 1995;108:S371-S379.
16. Horstkotte D. Prevention of intracardiac thrombosis and systemic embolism following heart valve replacement. Hemostaseology 1993;13:172-180.
17. Butchart EG, Lewis PA, Bethel PA, Breckenridge IM. Adjusting anticoagulation to prostheses thrombogenicity and patient risk factors: Recommendations for the Medtronic-Hall valve. Circulation 1991;84(Suppl. III):61-69.
18. Horstkotte D. Results with mechanical cardiac valvular prostheses. Ann Thorac Surg 1996;62:1565-1567.
19. Horstkotte D, Schulte HD, Bircks W, Strauer BE. Lower intensity anticoagulation therapy results in lower complication rates with the St. Jude Medical prosthesis. J Thorac Cardiovasc Surg 1994;107:1136-1145.
20. van den Besselaar AMHP, Breddin K, Lutze G, et al. Multicenter evaluation of a new capillary blood prothrombin time monitoring system. Blood Coagul Fibrinolysis 1995;6:726-732.
21. Horstkotte D, Piper C, Wiemer M, Schulte HD, Schultheiß HP. Improvement of prognosis by home prothrombin estimation in patients with life long anticoagulation therapy. Eur Heart J 1996;17(Suppl.):230.